Floatz logo

Levetiracetam

Acute Myeloid Leukemia

Center for International Blood and Marrow Transplant ResearchSmall moleculePhase 2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
59/ 100

Competitive context

587 Active assets in the Acute Myeloid Leukemia cohort.

Asset / SponsorPhaseRating
Gemtuzumab
M.D. Anderson Cancer Center
Phase 4A
AMSACRINE
University Hospital, Toulouse
Phase 4BBB
Posaconazole
AstraZeneca
Phase 4BBB
(+)-VINCRISTINE
Janssen Research & Development, LLC
Phase 3BBB
AKLAVINE
Chinese PLA General Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Levetiracetam is also rated in:

epilepsyActive
BBB
Indicative · Phase 4
74 / 100
View asset →
epilepsy with generalized tonic-clonic seizuresDormant
BB
Indicative · Phase 4
68 / 100
View asset →
acute lymphoblastic leukemiaActive
CCC
Indicative · Phase 2
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →